Human Research Ethics Committee approval received for Phase II trial of R327 for acute bacterial skin and skin structure infections (ABSSSI), including diabetic foot and wound infections New site ...

A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in ...

Preclinical data continues to demonstrate RECCE ® 327’s significant bactericidal activity against Neisseria gonorrhoeae (N. gonorrhoeae), with a 4-log (99.99%) and 3.5-log (>99.9%) reduction N.

To get a sense of who is truly in control of Recce Pharmaceuticals Ltd (ASX:RCE), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's ...

Host Tylah Tully looks at the latest news from Recce Pharmaceuticals (ASX:RCE), which has secured a cash refund of more than ...

Recce Pharmaceuticals Ltd (ASX:RCE) shareholders should be happy to see the share price up 20% in the last month. But that can't change the reality that over the longer term (five years), the returns ...

Recce, a new film & TV recommendation app designed to cure content overload and bring clarity to viewer decision fatigue, has launched. With an intuitive interface, and a community centric approach, ...